Matisse Capital
- SEC CIK
- 0001668256
- Latest filing
- Aug 12, 2026
HQL holding history
abrdn Life Sciences Investors in every 13F filed by Matisse Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HQL overviewAll 13F holders of HQLFull Q2 2026 holdings
- Shares (Q2 2024)
- 0
- Sold out in Q2 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2024 | 0 | $0 | 0.0% | −34,333−100.0% | Sold out | Holders |
| Q1 2024 | 34,333 | $468.0K | 0.2% | +24,333+243.3% | Added | Holders |
| Q4 2023 | 10,000 | $134.6K | 0.1% | +10,000 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −165,000−100.0% | Sold out | Holders |
| Q2 2021 | 165,000 | $3.54M | 1.1% | −154,311−48.3% | Reduced | Holders |
| Q1 2021 | 319,311 | $6.29M | 1.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.